Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamibarotene (AM80) for lupus nephritis
jRCT2080221132Phase 2Completed
- Sponsor
- Masanori Funauchi
- Start
- Jun 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of tamibarotene in lupus nephritis (LN) and systemic lupus erythematosus (SLE) (2 arms), sponsored by Masanori Funauchi. Started Jun 2010; status: completed.
02
Drugs
tamibarotene
03
Conditions
lupus nephritis (LN)systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on jRCT2080221132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221132.